Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Onconetix, Inc.

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort
From Onconetix, Inc.
Via GlobeNewswire
Tickers ONCO
Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress
From Onconetix, Inc.
Via GlobeNewswire
Tickers ONCO
Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing
From Onconetix, Inc.
Via GlobeNewswire
Tickers ONCO
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
From Onconetix, Inc.
Via GlobeNewswire
Tickers ONCO
Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
From Onconetix, Inc.
Via GlobeNewswire
Tickers ONCO
Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
From Onconetix, Inc.
Via GlobeNewswire
Tickers ONCO
Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds
From Onconetix, Inc.
Via GlobeNewswire
Tickers ONCO
Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds
From Onconetix, Inc.
Via GlobeNewswire
Tickers ONCO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.